BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181001
DTEND;VALUE=DATE:20181003
DTSTAMP:20260515T013418
CREATED:20180530T111706Z
LAST-MODIFIED:20180530T112721Z
UID:16014-1538352000-1538524799@www.pharmajournalist.com
SUMMARY:6th Plant Genomics & Gene Editing Congress: USA
DESCRIPTION:Attracting scientists working in all areas of plant research\, the conference\, held on October 1-2 2018\, will examine the latest strategies\, technologies and research techniques utilizing NGS\, ‘omic’ technologies\, phenotyping\, epigenetics\, bioinformatics\, regulation and data analysis to further plant research. \nTo find out more information\, please visit our website:\nhttp://www.global-engage.com/event/plant-genomics-usa/ \nOr email us at info@globalengage.co.uk \nCo-Located with the 3rd Partnerships in Biocontrol\, Biostimulants\, & Microbiome USA
URL:https://www.pharmajournalist.com/event/6th-plant-genomics-gene-editing-congress-usa/
LOCATION:The Logan Philadelphia\, One Logan Square\, Philadelphia\, PA\, 19103\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181001
DTEND;VALUE=DATE:20181003
DTSTAMP:20260515T013418
CREATED:20180530T112357Z
LAST-MODIFIED:20180530T112357Z
UID:16023-1538352000-1538524799@www.pharmajournalist.com
SUMMARY:3rd Partnerships in Biocontrol\, Biostimulants\, & Microbiome: USA
DESCRIPTION:Attracting experts working in all areas of plant science\, the conference\, held on October 1-2\, 2018 in Philadelphia\, will examine the latest developments in the technologies and techniques being used for developing biopesticides and biostimulants research\, EU regulation\, as well as the future of the industry. \nURL: http://www.global-engage.com/event/agricultural-biologicals/ \nCo-Located with the 6th Plant Genomics & Gene Editing Congress: USA
URL:https://www.pharmajournalist.com/event/3rd-partnerships-in-biocontrol-biostimulants-microbiome-usa/
LOCATION:Philadelphia\, USA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181008
DTEND;VALUE=DATE:20181010
DTSTAMP:20260515T013418
CREATED:20180411T074155Z
LAST-MODIFIED:20180522T120949Z
UID:14359-1538956800-1539129599@www.pharmajournalist.com
SUMMARY:Global Biobanking Congress
DESCRIPTION:Designed to attract industry leaders and academics\, this conference will look at ways to optimize biosample management and consider the future of emerging technologies such as mobile biobanking\, digital & cloud-based sample management and automated storage & retrieval systems. Key topics will also include data protection\, data sharing\, and the importance of ethical and regulatory considerations for maximising clinical impact. The Congress will provide a forum to network\, learn\, and engage with experts and representatives from pharmaceutical companies\, leading institutions\, and recognised biobanks worldwide.
URL:https://www.pharmajournalist.com/event/global-biobanking-congress/
LOCATION:TBC\, London\, United Kingdom\, United Kingdom
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181009
DTEND;VALUE=DATE:20181011
DTSTAMP:20260515T013418
CREATED:20180717T104113Z
LAST-MODIFIED:20180717T104113Z
UID:16780-1539043200-1539215999@www.pharmajournalist.com
SUMMARY:Outsourcing in Clinical Trials DACH 2018
DESCRIPTION:We are pleased to announce that the OCT series is extending to Switzerland 2018 to bring innovative and solutions focused content to the DACH biopharmaceutical market. Spinning off from the flagship OCT Europe event this intimate audience of local players allows for focused\, lucrative learning and networking on site. \n \nThrough in-depth research conducted with local biopharma companies\, this event will deliver insight\, debate\, discussion\, presentation and opinion on high priority outsourcing\, operations and technology-based themes within the clinical trials space locally. \nKey Agenda Highlights 2018\n1) Building collaborations with external providers to guarantee the best delivery through innovation. (Gisele Tavares\, Procurement – Global Head Alliance Management and Internal Business Partner at Roche) \n2) Onstage Interview: Working to foster a reputation in clinical development to partner with large solution providers for trusted timelines and high-quality deliverables – (Dirk Weber\, Chief Medical Officer at Cellestia Biotech AG/Aurealis Pharma AG) \n3) Considerations in observational research – the importance of long-term partnerships – (Pamela Bacon\, Head of Medical Affairs Communications and Operations\, Worldwide Markets at Celgene)  \nWhy must you attend? \nOCTDACH brings recognised experts specifically in the DACH region to discuss\, collaborate and network with a variety of key service providers as well as other biopharmaceuticals from innovative and collaborative ideas to help overcome challenges. \nThis event will deliver insights\, debates\, discussions\, presentations and opinion on high priority outsourcing\, operations and technology-based themes within the clinical trial space locally. \nTo learn more about this event\, and to register online\, visit http://bit.ly/OCTDASH2018 \nContact: \nPhone – +44 (0) 207 936 6521\nEmail – brijesh.patel@arena-international.com
URL:https://www.pharmajournalist.com/event/outsourcing-in-clinical-trials-dach-2018/
LOCATION:Radisson Blu\, Zurich Airport\, Rondellstrasse\, 8058 Kloten\, CH-8058
ORGANIZER;CN="Arena International":MAILTO:brijesh.patel@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181010
DTEND;VALUE=DATE:20181012
DTSTAMP:20260515T013418
CREATED:20180507T072343Z
LAST-MODIFIED:20180507T090028Z
UID:15692-1539129600-1539302399@www.pharmajournalist.com
SUMMARY:Cell & Gene Therapy 2018
DESCRIPTION:SMi introduces their inaugural event on Cell & Gene Therapy which takes place between the 10th and 11th October 2018\, with an interactive pre-conference workshop on the 9th October. \n\nCell and gene therapeutics have revolutionised modern medicine and mark a new generation in biomedical and agricultural sciences. The latest developments in cell and gene therapies and specifically in gene editing\, technologies present unlimited research opportunities ranging from novel therapeutic tools to a potential revolution in the field of drug discovery. \nThis year’s event will be led by scientists and clinicians researching\, developing and testing new treatments for genetically inherited and acquired diseases using gene delivery technology\, stem cell manipulation and DNA repair techniques. The conference will cover all aspects of the subject\, including biomedical science principles\, molecular basis of disease\, current and developing technologies and clinical applications. \nThe conference will be inviting speakers from global pharmaceutical organisations\, leading biotech companies and internationally renowned academic institutions Expect over 16 presentations and case studies focused on the key aspects of GMP\, bioprocessing\, regulatory frameworks and new therapeutic developments in in the field of cell and gene. \nHear from our expert speaker panel\, bringing you interesting case studies and detailed presentations on new and industry relevant topics\, including: \n\nCell Therapy Research\nManufacturing Innovation\nGlobal Medical Affairs\nRegulatory Updates\nGMP and Quality Control\nCell and Tissue Therapies (CART therapies\, stem cells\, cord blood\, preclinical and clinical developments)\nRegenerative Medicine\nAdvanced Therapy Production\nGene Therapy Development\nClinical Platform Development\nManufacturing\nR&D of Cell and Gene Therapies\n\nCHAIR FOR 2018: \n\nPamela Tranter\, Head of Translational Research Group\, UCL\n\nKEY SPEAKERS INCLUDE: \n\nJanet Glassford\, Senior Quality Assessor (Biologicals)\, MHRA\nGiuseppe Ronzitti\, Cell and Gene Therapy Specialist\, Genethon\nKei Kishimoto\, Chief Scientific Officer\, Selecta Biosciences\nShailesh Gupta\, Senior Scientist\, AstraZeneca\nPeggy Sotiropoulou\, R&D Manager\, Research and Development\, Celyad\nJulie Kerby\, Head of Manufacturing Development\, Cell and Gene Therapy Catapult\nLior Raviv\, Vice President\, Development\, Pluristem\nDiego Aridgo\, R&D Rare Disease Unit Head\, Chiesi\nMehdi Gasmi\, Chief Science and Technology Officer\, Adverum Biotech\nEmanuela Cuomo\, Associate Director\, Discovery Sciences\, Cellular Biology Team\, AstraZeneca\nYen Choo\, Founder and Executive Chairman\, Plasticell\nIan McKay\, Innovation Lead Advanced Therapies\, Innovate UK\n\n2018 FEATURED HIGHLIGHTS: \n\nDiscuss the challenges of accessing patients with commercial ATMPs\nUnderstand the advantages of a risk-based approach to cell and gene therapy manufacturing\nHear the MHRA’s perspective of UK and EU regulatory affairs regarding ATMPs\nExplore the unique applications of the CRISPR/Cas9 system for drug development at AstraZeneca\nGain insight into GMP Manufacture of plasmid DNA at the NHSBT\n\nView the full agenda online: www.cellandgeneconference.com/pj \nEARLY-BIRD RATES: \n\nREGISTER BY 31ST MAY AND SAVE £400\nREGISTER BY 29TH JUNE AND SAVE £300\nREGISTER BY 31ST AUGUST AND SAVE £200
URL:https://www.pharmajournalist.com/event/cell-gene-therapy-2018/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:psolanki@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181010
DTEND;VALUE=DATE:20181013
DTSTAMP:20260515T013418
CREATED:20180627T065536Z
LAST-MODIFIED:20180627T070348Z
UID:16489-1539129600-1539388799@www.pharmajournalist.com
SUMMARY:BioNetwork
DESCRIPTION:BioNetwork\n\nOctober 10 – 12\, 2018\nThe Ritz-Carlton\, Laguna Niguel\, CA. One\, Ritz Carlton Dr\, Dana Point\, CA 92629 \n\nBioNetwork is the essential deal-making event for business development executives in pharmaceutical and biotechnology. You’ll nurture strategic partnerships in our beautiful\, intimate venue. Pharma/Big Biotechs – register with code BIO18PHARMA and get 15% off your pass! \nTo learn more about this event\, and to register online\, visit bionetwork.wbresearch.com
URL:https://www.pharmajournalist.com/event/bionetwork/
LOCATION:The Ritz-Carlton\, Laguna Niguel\, One Ritz Carlton Drive\, Dana Point\, CA\, 92629\, United States
ORGANIZER;CN="Worldwide Business Research":MAILTO:bionetwork@wbresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181016
DTEND;VALUE=DATE:20181019
DTSTAMP:20260515T013418
CREATED:20171106T104802Z
LAST-MODIFIED:20180802T154835Z
UID:3828-1539648000-1539907199@www.pharmajournalist.com
SUMMARY:12th Digital Pharma East
DESCRIPTION:Join more than 800 attendees for the largest event focused exclusively on digital marketing for the life sciences — Digital Pharma East. Our faculty of more than 120 senior-level professionals share their lessons learned and actionable insights to help you leverage innovation to provide an optimal customer experience and improve health outcomes. \n  \nTo learn more about this event\, and to register online\, visit digitalpharmaseries.com/east
URL:https://www.pharmajournalist.com/event/12th-digital-pharma-east/
LOCATION:Pennsylvania Convention Center\, 1101 Arch Street\, Philadelphia\, PA\, 19107\, United States
ORGANIZER;CN="ExL Events":MAILTO:digitalpharma@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181016
DTEND;VALUE=DATE:20181018
DTSTAMP:20260515T013418
CREATED:20180628T105002Z
LAST-MODIFIED:20180628T110758Z
UID:16509-1539648000-1539820799@www.pharmajournalist.com
SUMMARY:LogiMed 2018
DESCRIPTION:LogiMed 2018 | Date: 16 – 17 October\, 2018 | Venue: Novotel Amsterdam City Amsterdam \nLogiMed is the only European event designed for medical device supply chain directors and their teams. It is where Heads of Supply Chain and Logistics from the top pharma companies in Europe gather to benchmark\, interact\, network and develop professionally. \n \nDownload the agenda to find out exactly who is speaking\, what the hottest topics are and how LogiMed can benefit you. LogiMed 2018 will bring together 150 Medical Device Supply Chain Professionals and 45 expert speakers over 2 value packed days. \nMixing interactive presentations from Global Heads of Supply Chain with practical\, interactive ‘how to’ case studies from proven procurement experts\, LogiMed helps Medical Device Manufacturers to transform their supply chain. \nAs a proud sponsor of the event\, we are pleased to offer you an exclusive 15% discount off the full price to attend\, using our code: LG18PJ \nTo learn more about LogiMed 2018\, and to register online\, visit http://bit.ly/2Mf2l7v
URL:https://www.pharmajournalist.com/event/logimed-2018/
LOCATION:Novotel Amsterdam City\, Amsterdam\, Netherlands
ORGANIZER;CN="Worldwide Business Research":MAILTO:Helmi.Pikarinen@wbr.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181016
DTEND;VALUE=DATE:20181018
DTSTAMP:20260515T013418
CREATED:20180820T083550Z
LAST-MODIFIED:20180820T083550Z
UID:17281-1539648000-1539820799@www.pharmajournalist.com
SUMMARY:Outsourcing Clinical Trials Pacific Northwest 2018
DESCRIPTION:The global OCT series will be returning once again to the Pacific Northwest to celebrate the best in clinical trial management. In 2018 we’ll be visiting Vancouver and will be building on the success of our Seattle 2017 launch. \n \nWe’ll be showcasing best in class local trial sponsors and you can expect a series of keynotes\, panel debates and roundtables on the biggest issues of the day. \nWe’ll be showcasing best in class local trial sponsors and you can expect a series of keynotes\, panel debates\, workshops and roundtables on the biggest issues of the day. \nThe 2018 agenda highlights include a Keynote session exploring how to underpin and sustain your competitive advantage in the PNW region; an interactive panel discussion comparing experiences with local vs international trials; and a regulatory update to pinpoint what you should be considering when it comes to clinical regulatory aspects. \nJoin us in Vancouver on October 16th & 17th to discuss\, deliberate and debate the latest operational and outsourcing challenges in conducting your clinical trials. \nBook your place now to avoid disappointment! \nTo learn more about this event\, and to register online\, visit http://www.arena-international.com/octpnw
URL:https://www.pharmajournalist.com/event/outsourcing-clinical-trials-pacific-northwest-2018/
LOCATION:Vancouver
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181017
DTEND;VALUE=DATE:20181019
DTSTAMP:20260515T013418
CREATED:20170814T012616Z
LAST-MODIFIED:20180427T162111Z
UID:2856-1539734400-1539907199@www.pharmajournalist.com
SUMMARY:European Drug Safety Summit 2018
DESCRIPTION:ACI’s European Drug Safety Summit 2018 will take place in London on 17th & 18th October. The two day event will bring together pharmacovigilance personnel from key pharmaceutical companies and will address the challenges in monitoring and maintaining drug safety strategies. The event will also discuss how to apply new technologies and strategic approaches to effectively manage drug safety and will discover key developments in the handling\, analysis and reporting of adverse events during trials and understand the regulators requirements with the aim of speeding drugs to market whilst mitigating the risk of recall. \nKey Topics Include: \n\nMeeting Safety Requirement: Regulator’s Perspective\nBuilding a Pharmacovigilance Strategy\nEvolving PV Strategies for Tomorrow\nTechnological Advancement in Pharmacovigilance\nClinical Data Management\nThe Role of Big Data and Social Media in PV\nEnsure Drug Safety & Risk Minimisation Measures\nLatest Development & Innovation Approach for Effective Signal Management\nDevelopment of Qualified Personal Responsible for Pharmacovigilance (QPPV)\nPharmacovigilance for Advanced Therapies\n\nWho Will Attend? \nAttendees will be drawn primarily from pharmaceutical\, biotechnology and contract research organisations and include VPs\, Directors and Managers/Scientists working in Drug Safety\, Pharmacovigilance\, Epidemiology\, Clinical Research and Development\, Clinical Trial Management\, Pharmacology\, Regulatory Affairs and Compliance\, Strategy and Business Development\, Risk Management\, QPPV.
URL:https://www.pharmajournalist.com/event/european-drug-safety-summit-2018/
LOCATION:London\, UK
ORGANIZER;CN="ACI":MAILTO:cwilliams@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181017
DTEND;VALUE=DATE:20181019
DTSTAMP:20260515T013418
CREATED:20180116T100210Z
LAST-MODIFIED:20180808T084554Z
UID:7746-1539734400-1539907199@www.pharmajournalist.com
SUMMARY:Pharma Cold Chain Summit 2018
DESCRIPTION:ACI’s Pharma Cold Chain Summit 2018 will be taking place on the 17th & 18th October in London\, UK. The two day event will bring together leading experts and stakeholders from across the sector for two days of engaging presentations and interactive discussions. The core challenges and critical issues will be tackled to maintain a robust Cold Chain Management across the global Pharmaceutical Supply Chain. \nJoin us for a balanced programme of practical\, commercial\, case-study-based discussions\, and to meet industry thought leaders and senior-level decision-makers in an informal environment ideal for sharing ideas and making new contacts. \nAgenda: http://bit.ly/2D3csY7
URL:https://www.pharmajournalist.com/event/pharma-cold-chain-summit-2018/
LOCATION:Virtual Conference: Online Access Only
ORGANIZER;CN="Active Communications International%2C Europe":MAILTO:rbaryah@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181017
DTEND;VALUE=DATE:20181019
DTSTAMP:20260515T013418
CREATED:20180511T115222Z
LAST-MODIFIED:20180511T115339Z
UID:15781-1539734400-1539907199@www.pharmajournalist.com
SUMMARY:Orphan Drugs and Rare Diseases Conference
DESCRIPTION:This year’s SMi’s Orphan Drugs and Rare Diseases Conference will bring together regulatory agencies\, pharmaceutical companies\, non-profit organisations and orphan drugs developers to construct an agenda that addresses the driving economic factors\, policies and issues that will affect the development of orphan drugs globally including commercialization\, policies\, reimbursement\, and pricing. \nKeep up to date with the industry and to learn from expert speaker panel\, bringing you important new case studies and reports on this year’s relevant topics. \n\nHIGHLIGHTS IN 2018: \n\nDiscuss the pricing and reimbursement of orphan drugs\nUnderstand the challenges of patient recruitment and patient-centric research\nHear the MHRA’s perspective on benefit-risk assessment in rare diseases\nExplore the clinical development of orphan drugs for rare disease\nGain insight into potential synergies between regulators and assessors\n\nSPEAKERS INCLUDE: \n\nCarina Schey\, Researcher\, University of Groningen\nSheela Upadhyaya\, Associate Director\, Highly Specialised Technologies\, National Institute for Health and Care Excellence (NICE)\nXavier Ortega\, Project Manager\, Rare Diseases\, Minoryx\nNigel Nicholls\, Director and Country Manager UK/Ireland\, BioMarin Europe Ltd\nYolanda Barbachano\, Senior Statistical Assessor\, MHRA\nMichale Bouskila-Chubb\, Head of Business Development\, Healx\n\nView detailed agenda\, find out who is speaking and book to attend at http://www.orphandrugs.co.uk/phjWL \nTwitter – @SMIpharm & #smiorphandrugs\nLinkedIn – SMi Pharma\nOpt-in – SMi Group value your interest in their events and would like to stay in touch – opt-in via https://www.smi-online.co.uk/opt-in to receive SMi’s updates
URL:https://www.pharmajournalist.com/event/orphan-drugs-and-rare-diseases-conference/
LOCATION:Holiday Inn Kensington Forum\, London\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:ldurneva@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181022
DTEND;VALUE=DATE:20181025
DTSTAMP:20260515T013418
CREATED:20180803T124056Z
LAST-MODIFIED:20180803T124308Z
UID:17024-1540166400-1540425599@www.pharmajournalist.com
SUMMARY:Gene Therapy for Rare Disorders Europe Summit
DESCRIPTION:2018 is the year gene therapies come into their own. After decades on unfulfilled potential\, this space is gaining tangible momentum\, particularly in addressing the significant unmet need in a range of rare diseases. \n \nGene Therapy for Rare Disorders Europe is the uniquely focused conference uniting industry leaders to discuss the late-stage challenges that need to be overcome to deliver more gene therapies to market. \nRather than early stage basic science\, this meeting is solely devoted to addressing the latest clinical\, manufacturing\, regulatory and commercialization challenges facing this rapidly evolving field. This is a comprehensive guide to define your commercial path forward. Visit the website to see the full agenda\, speaker line-up\, registration costs and more: https://bit.ly/2KoxFys \nClaim a special 10% discount when you quote 9709PJ1 at the checkout. \nContact:\n+44 (0)20 3141 8700\ninfo@hansonwade.com
URL:https://www.pharmajournalist.com/event/gene-therapy-for-rare-disorders-europe-summit/
LOCATION:Novotel London West\, London
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181022
DTEND;VALUE=DATE:20181025
DTSTAMP:20260515T013418
CREATED:20180808T114904Z
LAST-MODIFIED:20180808T114904Z
UID:17066-1540166400-1540425599@www.pharmajournalist.com
SUMMARY:Precision CRISPR Drug Discovery and Gene Therapy Congress 2018
DESCRIPTION:Precision CRISPR Congress\, 22-24 October 2018 | London\, UK is a meeting dedicated to supporting pharma and biotech community in realising the drug discovery and gene therapy applications of optimised CRISPR systems. Joining this community will enable you to hear and share the latest CRISPR advances and help accelerate research that will develop solutions to get CRISPR gene therapy into the clinic faster. \n\n\nWith Cornlab recent move to Switzerland\, meet its Principal Investigator Jacob Corn and learn about Gene Repair in Human Hematopoietic Stem Cells.\nDiscover how to detect in vitro & ex vivo cellular indel profiles and dynamics induced by different CRISPR/Cas9 delivery formats with insights from Eric Paul Bennett\, University of Copenhagen\nFind out how Barry Rosen\, VP\, AstraZeneca is utilising precise genome engineering to empower drug discovery \n\nSounds interesting? Join us this  October in London and be part of a dedicated community in Europe\, striving to realise the drug discovery & gene therapy applications of optimised CRISPR systems. \nTo learn more about this event\, visit http://bit.ly/2AToGpK
URL:https://www.pharmajournalist.com/event/precision-crispr-drug-discovery-and-gene-therapy-congress-2018/
LOCATION:The Hilton London Olympia\, 380 Kensington High St\, Kensington\, London\, W14 8N\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:tom.hill@crispr-europe.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181023
DTEND;VALUE=DATE:20181025
DTSTAMP:20260515T013418
CREATED:20180716T063217Z
LAST-MODIFIED:20180717T094508Z
UID:16752-1540252800-1540425599@www.pharmajournalist.com
SUMMARY:Healthcare Supply Chain Management Summit 2018
DESCRIPTION:Healthcare Supply Chain Management Summit 2018 will delve on the aspects of gaining greater competency in supply chain management to better manage costs\, weather the storm of impending legislation and identify the tools in place to enable organizations to boost their supply chain procedures by offering a mix of thought provoking and practical sessions while covering a wide range of topics along with a unique industry networking platform. \n \nTo register or download the complete agenda visit https://bit.ly/2mkhSqP \nContact:\nEmail – p.nagvekar@inventicon.in\nPhone – +91 22 66089643
URL:https://www.pharmajournalist.com/event/healthcare-supply-chain-management-summit-2018/
LOCATION:Holiday Inn Mumbai International Airport\, Mumbai\, India\, Mumbai\, India
ORGANIZER;CN="Inventicon Business Intelligence":MAILTO:p.nagvekar@inventicon.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181029
DTEND;VALUE=DATE:20181031
DTSTAMP:20260515T013418
CREATED:20180502T074142Z
LAST-MODIFIED:20180502T075032Z
UID:15540-1540771200-1540943999@www.pharmajournalist.com
SUMMARY:6th Microbiome R&D and Business Collaboration Forum: USA
DESCRIPTION:The 6th Microbiome R&D and Business Collaboration Forum: USA which will be held on 29-30 October\, 2018 and will be co-located with the 3rd Probiotics Congress: USA. \nLast year’s congress attracted 400 industry\, academic and investment leaders to discuss the microbiome in health and disease; challenges and opportunities in moving research towards commercialization; and potential partnerships and collaborations. \n\nAttendees are expected to converge on San Diego this fall to hear a 70-strong speaker faculty discuss the latest developments; engage in expert-led roundtable discussions and extended panel discussions; analyse the newest biotech’s and start-ups worthy of investment; and utilise over seven hours of dedicated networking time to broaden business connections within the field. The Global Engage series is rapidly gaining a fantastic reputation as the number one microbiome networking event. If looking to either learn more from the top scientists in the microbiome and probiotic space; showcase exciting developments in your research; or seek partnerships and funding within the industry; it is a congress not be missed. \nInterested? Download the agenda: http://www.global-engage.com/event/microbiome/#agenda/?utm_source=mp18
URL:https://www.pharmajournalist.com/event/6th-microbiome-rd-and-business-collaboration-forum-usa/
LOCATION:Paradise Point Resort & Spa\, San Diego
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181029
DTEND;VALUE=DATE:20181031
DTSTAMP:20260515T013418
CREATED:20180926T085309Z
LAST-MODIFIED:20180926T085408Z
UID:17764-1540771200-1540943999@www.pharmajournalist.com
SUMMARY:Microbiome R&D and Business Collaboration Forum: USA
DESCRIPTION:As part of its worldwide microbiome series\, Global Engage is pleased to announce the 6th Microbiome R&D and Business Collaboration Forum: USA which will be held on 29-30 October\, 2018 and will be co-located with the 3rd Probiotics Congress: USA. \nLast year’s congress attracted 400 industry\, academic and investment leaders to discuss the microbiome in health and disease; challenges and opportunities in moving research towards commercialization; and potential partnerships and collaborations. \nAttendees are expected to converge on San Diego this Fall to hear a 70-strong speaker faculty discuss the latest developments; engage in expert-led roundtable discussions and extended panel discussions; analyse the newest biotechs and start-ups worthy of investment; and utilise over seven hours of dedicated networking time to broaden business connections within the field. \nThe Global Engage series is rapidly gaining a fantastic reputation as the number one microbiome networking event. If looking to either learn more from the top scientists in the microbiome and probiotic space; showcase exciting developments in your research; or seek partnerships and funding within the industry; it is a congress not to be missed. \nFor more information please visit our website: http://www.global-engage.com/event/microbiome/?utm_source=pjmp \nOr email info@globalengage.co.uk
URL:https://www.pharmajournalist.com/event/microbiome-rd-and-business-collaboration-forum-usa/
LOCATION:Paradise Point Resort & Spa\, San Diego\, USA\, San Diego\, United States
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181030
DTEND;VALUE=DATE:20181101
DTSTAMP:20260515T013418
CREATED:20180820T084126Z
LAST-MODIFIED:20180820T084126Z
UID:17285-1540857600-1541030399@www.pharmajournalist.com
SUMMARY:Outsourcing Clinical Trials Nordics 2018
DESCRIPTION:Following on from the success of the 2017 Outsourcing in Clinical Trials Nordics conference\, Arena International is pleased to announce that the event will return for its 6th year in 2018. \n \nThe 2018 event welcomes biopharmaceutical and medical device companies from across the Nordic region to share knowledge and challenges of outsourcing and clinical operations. \nDelegates will hear from the most innovative companies in the region on how they have developed their outsourcing and clinical operations strategies. Issues such as deciphering methods to preventing time delays and outlining a rational approach between third-parties\, achieving greater financial transparency into refining collaborative terms with your partners. \nThe conference further welcomes a unique Medical Device stream which includes an array of successful Nordic companies. The stream will discuss the new MDR regulations and the challenges it has come with. There will be presentations on securing economic for start-up companies and also the opportunity to participate in a unique workshop on building a clinical expertise group specific to the Nordic region. \nThrough constant collaboration and support with members of the local industry\, this conference features the latest trends in clinical outsourcing and operational development within the medical device and pharmaceutical industry. Delegates will leave with a range of strategies and inspiration to apply to the operation running of their clinical trials. \nDon’t miss out on this unique event; register your place today! \nTo learn more about this event\, and to register online\, visit http://www.arena-international.com/octnordics
URL:https://www.pharmajournalist.com/event/outsourcing-clinical-trials-nordics-2018/
LOCATION:Copenhagen\, Denmark
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
END:VCALENDAR